AI-generated summary
The authors retrospectively reviewed 100 patients treated with a 1,064 nm Nd:YAG laser for facial reticular veins, using office follow-up or telephone interviews. They report that 89 patients rated their satisfaction as 3 or very satisfied, most reported 75% to 100% vein improvement, and 68% reported no adverse effects. The authors describe the treatment as safe and effective with minimal side effects.
- Participants
- 100
- Who or what was studied
- Patients with facial reticular veins in the periorbital and temporal area treated with a 1,064 nm Nd:YAG laser between 2006 and 2019.
- Limits stated in the abstract
- The study is a retrospective review of 100 patients that relied partly on telephone interviews to assess outcomes, with no control group described in the abstract.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 064 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Adverse event. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.